| Literature DB >> 28963525 |
Irina Fierascu1,2, Milen I Georgiev1,3, Alina Ortan4, Radu Claudiu Fierascu5,6, Sorin Marius Avramescu1,7, Daniela Ionescu1,8, Anca Sutan9, Alexandru Brinzan10, Lia Mara Ditu11.
Abstract
The development of methods for obtaining new materials with antimicrobial properties, based on green chemistry principles has been a target of research over the past few years. The present paper describes the phyto-mediated synthesis of metallic nano-architectures (gold and silver) via an ethanolic extract of Melissa officinalis L. (obtained by accelerated solvent extraction). Different analytic methods were applied for the evaluation of the extract composition, as well as for the characterization of the phyto-synthesized materials. The cytogenotoxicity of the synthesized materials was evaluated by Allium cepa assay, while the antimicrobial activity was examined by applying both qualitative and quantitative methods. The results demonstrate the synthesis of silver nanoparticles (average diameter 13 nm) and gold nanoparticles (diameter of ca. 10 nm); the bi-metallic nanoparticles proved to have a core-shell flower-like structure, composed of smaller particles (ca. 8 nm). The Ag nanoparticles were found not active on nuclear DNA damage. The Au nanoparticles appeared nucleoprotective, but were aggressive in generating clastogenic aberrations in A. cepa root meristematic cells. Results of the antimicrobial assays show that silver nanoparticles were active against most of the tested strains, as the lowest MIC value being obtained against B. cereus (approx. 0.0015 mM).Entities:
Mesh:
Substances:
Year: 2017 PMID: 28963525 PMCID: PMC5622205 DOI: 10.1038/s41598-017-12804-7
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Major and minor compounds identified by GC-MS in the Melissa officinalis L. extract.
| No. | Compound | RT (min.) | Area (%) |
|---|---|---|---|
| 1 | N-Benzyloxycarbonyl-dl-norleucine | 13.517 | 0.9414 |
| 2 | Benzyl methanoate | 13.769 | 0.0377 |
| 3 | Methyl N-(N-benzyloxycarbonyl-beta-l-aspartyl)-beta-d-glucosaminide | 14.158 | 0.0423 |
| 4 | dl-Leucine, N-[(phenylmethoxy)carbonyl]- | 14.283 | 0.0205 |
| 5 | (1 R)-(-)-Myrtenal | 14.395 | 0.2137 |
| 6 | Benzyl isopentyl ether | 14.832 | 0.3334 |
| 7 | Pentanedioic acid, dimethyl ester | 15.396 | 0.6908 |
| 8 | 4H-Pyran-4-one, 2,3-dihydro-3,5-dihydroxy-6-methyl- | 15.626 | 0.4311 |
| 9 | Isopulegol | 15.776 | 0.3918 |
| 10 | 3,7-Dimethyl-7-octenal | 15.874 | 0.7839 |
| 11 | 2,5-Octadecadiynoic acid, methyl ester | 17.187 | 0.2840 |
| 12 | N-Benzyl-2-phenethylamine | 17.609 | 0.9521 |
| 13 | 4-Hepten-3-one, 4-methyl- | 17.891 | 1.3241 |
| 14 | R-Limonene | 18.029 | 0.1368 |
| 15 | Hexanedioic acid, dimethyl ester | 18.345 | 1.1701 |
| 16 | Z,Z,Z-4,6,9-Nonadecatriene | 18.653 | 0.4412 |
| 17 | 2-Methoxy-4-vinylphenol | 20.321 | 0.4115 |
| 18 | Caryophyllene | 23.188 | 1.5957 |
| 19 | (3-Nitrophenyl) methanol, isopropyl ether | 23.438 | 10.3997 |
| 20 | Pyrrolizin-1,7-dione-6-carboxylic acid, methyl(ester) | 23.543 | 0.1999 |
| 21 | β-Hydroxylauric acid | 23.822 | 0.0424 |
| 22 | 2(4 H)-Benzofuranone, 5,6,7,7a-tetrahydro-4,4,7a-trimethyl-, (R)- | 24.714 | 0.3815 |
| 23 | Unidentified | 26.043 | 0.5917 |
| 24 | Caryophyllene oxide | 27.158 | 0.5790 |
| 25 | [1,1′-Bicyclopropyl]-2-octanoic acid, 2′-hexyl-, methyl ester | 27.288 | 0.0832 |
| 25 | 2-Myristynoyl pantetheine | 27.563 | 0.1947 |
| 26 | Cyclopropanetetradecanoic acid, 2-octyl-, methyl ester | 27.709 | 0.5649 |
| 27 | Agaricic acid | 28.191 | 0.1677 |
| 28 | 11,13-Dihydroxy-tetradec-5-ynoic acid, methyl ester | 28.394 | 0.5483 |
| 29 | 10-Heptadecen-8-ynoic acid, methyl ester, (E)- | 28.515 | 0.1399 |
| 30 | 6-epi-shyobunol | 28.662 | 0.1875 |
| 31 | Cyclopropanetetradecanoic acid, 2-octyl-, methyl ester | 28.784 | 0.4707 |
| 32 | 7-Methyl-Z-tetradecen-1-ol acetate | 28.838 | 1.5319 |
| 33 | 2-[4-methyl-6-(2,6,6-trimethylcyclohex-1-enyl)hexa-1,3,5-trienyl]cyclohex-1-en-1-carboxaldehyde | 29.381 | 0.2547 |
| 34 | 9-Hexadecenoic acid | 30.653 | 0.2862 |
| 35 | 7-Methyl-Z-tetradecen-1-ol acetate | 30.972 | 0.0883 |
| 36 | Cyclopent-2-ene-1-carboxylic acid, 2,3-dimethyl-1-ethyl-, ethyl ester | 31.071 | 7.1930 |
| 37 | Unidentified | 31.237 | 0.0216 |
| 38 | 10-Heptadecen-8-ynoic acid, methyl ester, (E)- | 31.486 | 0.7463 |
| 39 | 2-Methoxybenzoic acid, benzyl ester | 31.615 | 0.7083 |
| 40 | p-Hydroxycinnamic acid, ethyl ester | 32.066 | 0.2478 |
| 41 | Unidentified | 32.150 | 0.5987 |
| 42 | Neophytadiene | 32.345 | 11.5269 |
| 43 | 1.Hexa-hydro-farnesol | 32.469 | 0.6797 |
| 44 | 9-Octadecenoic acid, (2-phenyl-1,3-dioxolan-4-yl)methyl ester, trans- | 32.754 | 0.1129 |
| 45 | Phytol, acetate | 32.834 | 1.9646 |
| 46 | Phthalic acid, butyl undecyl ester | 33.008 | 0.4107 |
| 47 | 3,7,11,15-Tetramethyl-2-hexadecen-1-ol | 33.197 | 3.5572 |
| 48 | Palmitic acid | 34.711 | 7.1208 |
| 49 | Unidentified | 35.005 | 0.4174 |
| 50 | 9-Octadecenoic acid, (2-phenyl-1,3-dioxolan-4-yl)methyl ester, cis- | 35.164 | 0.5406 |
| 51 | Hexadecanoic acid, ethyl ester | 35.335 | 1.4563 |
| 52 | Caffeic acid | 36.727 | 1.5472 |
| 53 | Unidentified | 36.779 | 0.4635 |
| 54 | Phytol | 37.538 | 7.7461 |
| 55 | 13-Heptadecyn-1-ol | 37.863 | 1.3360 |
| 56 | Linolenic acid | 38.002 | 7.1616 |
| 57 | Oleic Acid | 38.337 | 0.7987 |
| 58 | 2-cis-9-Octadecenyloxyethanol | 38.393 | 0.7430 |
| 59 | Linolenic acid, ethyl ester | 38.523 | 0.8939 |
| 60 | 3-(Benzyloxymethyl)hex-5-ene-1,2-diol | 39.362 | 0.2389 |
| 61 | Unidentified | 40.453 | 0.4621 |
| 62 | 1-Heptatriacotanol | 41.718 | 0.2889 |
| 63 | Benzenepropionic acid, 4-benzyloxy- | 42.300 | 3.2737 |
| 64 | 5β)Pregnane-3,20β-diol, 14α,18α-[4-methyl-3-oxo-(1-oxa-4-azabutane-1,4-diyl)]-, diacetate | 42.784 | 0.3836 |
| 65 | Dipalmitin | 44.034 | 0.5934 |
| 66 | Diisooctyl phthalate | 44.689 | 5.0982 |
| 67 | 5H-Cyclopropa[3,4]benz[1,2-e]azulen-5-one, 2,9,9a-tris(acetyloxy)-3-[(acetyloxy)methyl]-1,1a,1b,2,4a,7a,7b,8,9,9a-decahydro-4a,7b-dihydroxy- 1,1,6,8-tetramethyl-, [1aR-(1aa,1bb,2b,4ab,7aa,7ba,8a,9b,9aa)]- | 44.972 | 0.3698 |
| 68 | 1H-Cyclopropa[3,4]benz[1,2-e]azulene-5,7b,9,9a-tetrol, 1a,1b,4,4a,5,7a,8,9-octahydro-3-(hydroxymethyl)-1,1,6,8-tetramethyl-, 5,9,9a-triacetate, [1aR-(1aa.,1bb.,4ab.,5.b.,7aa., 7b.a.,8.a.,9.b.,9a.a.)]- | 46.126 | 0.2082 |
| 69 | 4H-Cyclopropa[5′,6′]benz[1′,2′:7,8]azuleno[5,6-b]oxiren-4-one, 8-(acetyloxy)-1,1a,1b,1c,2a,3,3a,6a,6b,7,8,8a-dodecahydro-3a,6b,8a-trihydroxy-2a-(hydroxymethyl)-1,1,5,7-tetramethyl-, [1ar-(1aa.,1bb.,1 c.a.,2a.a.,3a.b.,6a.a.,6b.a.,7.a.,8.b.,8a.a.)]- | 46.692 | 0.1942 |
| 70 | 1-Heptatriacotanol | 46.818 | 1.0470 |
| 71 | 4,9,9a-Tris(acetyloxy)-3-[(acetyloxy)methyl]-1,1a,1b,4,4a,7a,7b,8,9,9a-decahydro-4a,7b-dihydroxy-1,1,6,8-tetramethyl-5H-cyclopropa[3,4]benz[1,2-e]azulen-5-one | 47.023 | 0.4588 |
| 71 | Unidentified | 47.533 | 0.4993 |
| 72 | 1H-Cyclopropa[3,4]benz[1,2-e]azulene-5,7b,9,9a-tetrol, 1a,1b,4,4a,5,7a,8,9-octahydro- 3-(hydroxymethyl)-1,1,6,8-tetramethyl-, 5,9,9a-triacetate, [1aR-(1a.aa.,1b.b.,4a.b., 5.b.,7a.a.,7b.a.,8.a.,9.b.,9a.a.)]- | 48.201 | 0.1081 |
| 73 | Ethyl iso-allocholate | 48.683 | 0.2764 |
| 74 | Unidentified | 48.952 | 0.2799 |
| 75 | Octadecane, 3-ethyl-5-(2-ethylbutyl)- | 49.551 | 1.3124 |
Where: RT – retention time (in minutes), area (%) – percent of the total area of the chromatogram.
HPLC quantification of eight known marker compounds of Melissa officinalis L.
| No. | Compound | Content (mg/kg), expressed on dry weight basis |
|---|---|---|
| 1 | Gallic acid | 7.438 ± 0.014 |
| 2 | Chlorogenic acid | 72.529 ± 0.24 |
| 3 | Ferulic acid | 45.489 ± 0.15 |
| 4 | Rosmarinic acid | 3502.399 ± 1.78 |
| 5 | Quercetin | 153.465 ± 0.32 |
| 6 | Apigenin | 84.538 ± 0.11 |
| 7 | Rutin | 1462.997 ± 1.24 |
| 8 | trans-Anethole | 85.876 ± 0.12 |
Figure 1UV-Vis spectra of the synthesized nanoparticles (A – silver nanoparticles, B – gold nanoparticles, C – silver/gold nano-architectures) and their stability in time. The characteristic peaks of silver and gold nanoparticles are presented.
Figure 2Energy-dispersive X-ray fluorescence spectra of the phytosynthesized nanoparticles (A – silver nanoparticles, B – gold nanoparticles, C – silver/gold nano-architectures). Specific peaks of gold and silver are presented.
Figure 3X-Ray diffractograms of the obtained nanoparticles (S – silver, O – silver oxides, G – gold).
Figure 4Transmission electron microscopy images and size distribution of the obtained nanoparticles (A – silver nanoparticles, B – gold nanoparticles, C and D – silver/gold nano-architectures).
Figure 5Impact of Melissa officinalis L. ethanolic extract and its metallic nanoarchitectures on the mitotic index of Allium cepa L. root cells exposed for 48 h. R – extract; S1 – silver nanoparticles solution; S2 – gold nanoparticles solution; S3 – gold/silver nanoparticles solution.
Effect of Melissa officinalis L. ethanolic extract and its biogenic nanoparticles on chromosomal aberrations in A. cepa L. root meristems.
| Sample exposure | Nuclear abnormalities | Chromosomes aberrations | |||
|---|---|---|---|---|---|
| Micronuclei | C-mitosis | Bridges | Vagrants | Laggards | |
| Control | — | — | — | 7.63 ± 3.82bc | 7.67 ± 2.55bc |
| R 10% | 0.13 ± 0.04c | — | — | 0.16 ± 0.03c | — |
| R 20% | 0.45 ± 0.07c | — | — | 0.74 ± 0.08c | — |
| S1 10% | 0.32 ± 0.08c | — | — | 0.45 ± 0.06c | — |
| S1 20% | 0.21 ± 0.03c | — | — | 1.14 ± 0.13c | — |
| S2 10% | — | 8.91 ± 2.5bc | 31.06 ± 9.67ab | 0.93 ± 00.22c | — |
| S2 20% | — | 16.20 ± 8.68bc | 48.41 ± 26.02a | 0.74 ± 0.23c | — |
| S3 10% | — | 49.73 ± 10.14a | 16.67 ± 16.67bc | 1.68 ± 0.20c | — |
| S3 20% | — | 10.57 ± 4.15bc | 26.11 ± 3.89abc | 0.82 ± 0.22c | — |
Where: R – extract, S1 – AgNP, S2-AuNP, S3 – Ag/AuNP; Values presented are mean ± SE. Means followed by the same letter not differ significantly (Duncan test, p > 0.05).
Qualitative evaluation of antimicrobial effects of tested samples expressed by inhibition zone diameters.
| No | Microbial strains | Inhibition zone diameters (mm) | ||||
|---|---|---|---|---|---|---|
| AgNP | AuNP | Ag/AuNP | Extract | Control | ||
| 1 |
| 12 | 0 | 13 | 0 | 0 |
| 2 |
| 20 | 11 | 17 | 10 | 0 |
| 3 |
| 12 | 12 | 0 | 0 | 0 |
| 4 |
| 15 | 0 | 12 | 0 | 0 |
| 5 |
| 11 | 0 | 9 | 0 | 0 |
| 6 |
| 10 | 0 | 10 | 0 | 0 |
| 7 |
| 0 | 0 | 0 | 0 | 0 |
| 8 |
| 7 | 7 | 7 | 0 | 0 |
| 9 |
| 0 | 0 | 0 | 0 | 0 |
| 10 |
| 0 | 0 | 0 | 0 | 0 |
Minimum inhibitory concentration of tested samples.
| No. | Microbial strains | Minimal inhibitory concentration values | |||
|---|---|---|---|---|---|
| AgNP (mM) | AuNP (mM) | Ag/AuNP (mM) | Extract | ||
| 1 |
| 0.0125 | 0.1 | 0.025 | Undiluted |
| 2 |
| 0.0015625 | 0.2 | 0.003125 | Undiluted |
| 3 |
| 0.003125 | 0.2 | 0.0125 | Undiluted |
| 4 |
| 0.00625 | 0.2 | 0.0125 | Undiluted |
| 5 |
| 0.003125 | 0.2 | 0.00625 | Undiluted |
| 6 |
| 0.0125 | 0.025 | 0.025 | Undiluted |
| 7 |
| 0.05 | 0.2 | 0.1 | Undiluted |
| 8 |
| 0.05 | 0.4 | 0.1 | Undiluted |
| 9 |
| 0.8 | 0.8 | 0.8 | Undiluted |
| 10 |
| 0.05 | 0.8 | 0.05 | Undiluted |
Minimal concentration for biofilm eradication values for tested samples, expressed in mM and FD – dilution factor (for the extract).
| No. | Microbial strains | Minimal concentration for biofilm eradication | ||||
|---|---|---|---|---|---|---|
| AgNP (mM) | AuNP (mM) | Ag/AuNP (mM) | Extract (dilution) | Control (mM) | ||
| 1 |
| 0.0125 | 0.4 | 0.025 | FD2 | 1712 |
| 2 |
| 0.0015625 | 0.2 | 0.003125 | FD4 | 856 |
| 3 |
| 0.00625 | 0.2 | 0.00625 | FD4 | 856 |
| 4 |
| 0.0125 | 0.4 | 0.0125 | FD2 | 856 |
| 5 |
| 0.00625 | 0.2 | 0.00625 | FD4 | 856 |
| 6 |
| 0.025 | 0.2 | 0.05 | FD4 | 428 |
| 7 |
| 0.00625 | 0.2 | 0.00625 | FD4 | 856 |
| 8 |
| 0.05 | 0.4 | 0.1 | FD4 | 856 |
Figure 6Proposed mechanism for the synthesis of metal nanoparticles using plant extracts (adapted from literature data[3,41,62]) and the reactions involved in the metal reduction to nanoparticle.